Revolutionizing AD retweeted
Join the RAD Conference in Nashville, June 6–7! Get expert insights from Drs. Silverberg and Chovatiya, plus two full days of CME. Bonus: It’s the same weekend as the country music festival—learn by day, enjoy music by night. Spots are limited: hubs.li/Q03gzt6d0 #RAD2025
Revolutionizing AD retweeted
Thrilled to share that Dr. Chovatiya will be joining me at Revolutionizing Atopic Dermatitis (RAD) on June 6-7 in Nashville, TN!
Use my code Silverberg for free registration and save your spot now: bit.ly/41D2vwU
#RAD #AtopicDermatitis #gotoper
Revolutionizing AD retweeted
David Rosmarin, MD, presented developments and advancements in both vitiligo and atopic dermatitis at #RAVE24. In his vitiligo discussion, Rosmarin reviewed phase 3 data of #ruxolitinib cream and key points from the subgroup analysis.
dermatologytimes.com/view/lo…
Revolutionizing AD retweeted
We are back at day 2 of #RAVE24 and getting ready for more expert interviews! Stay tuned for session insights throughout the day.
Revolutionizing AD retweeted
Jonathan Silverberg, MD, PhD, MPH, previews the new Revolutionizing Alopecia Areata, Vitiligo, and Eczema conference and how additional disease states will best serve clinicians treating multiple inflammatory conditions.
dermatologytimes.com/view/a-…
Revolutionizing AD retweeted
A poster presented at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema conference showed positive results in patients with alopecia areata with 25% or more hair loss with the use of #ritlecitinib.
dermatologytimes.com/view/ri…
Revolutionizing AD retweeted
After treatment with topical ruxolitinib cream, CXCL10 biomarker levels in patients with #vitiligo were significantly reduced, according to data presented in a poster at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference.
dermatologytimes.com/view/se…
Revolutionizing AD retweeted
Congratulations to Peter Lio, MD, for being this year's Totally RAD Award Winner!
Revolutionizing AD retweeted
Study investigators sought to develop a real-time based molecular classifier to distinguish #psoriasis from atopic #eczema in FFPE-fixed skin samples for diagnostic measures. #RAD2023
ow.ly/amVk50O4eOM
Revolutionizing AD retweeted
Catch up on coverage from the second day of #RAD2023.
ow.ly/8N3i50O4s6i
Revolutionizing AD retweeted
In a dual-speaker session Sunday, Andrew Blauvelt, MD, MBA, discussed systemic treatment eligibility for patients with #AtopicDermatitis alongside Jonathan Silverberg, MD, PhD, MPH.
ow.ly/hyOQ50O4lvP
Revolutionizing AD retweeted
A recent network meta-analysis from @JonathanMd and colleagues highlights the efficacy of upadacitinib 30 mg for treating moderate to severe atopic dermatitis without topical corticosteroids. Find out more about the findings from #RAD2023:
ow.ly/GrmN50O4f59
Revolutionizing AD retweeted
The Impact of Swimming on Atopic Dermatitis Flares- Now available on Dermatology Times
To read the full article go to tinyurl.com/3kweus6s
#DNA #AtopicDermatitis #Flares #Dermatology #Nursing #Nurses #Growth #GrowthIsInOurDNA #Education
Revolutionizing AD retweeted
In this interview, Anne Marie Singh, MD, discussed her presentation from the @RevAtopicDerm on allergy testing for infants with #AtopicDermatitis.
Check out the interview here: ow.ly/rgpM50O4iYA
#eczema #allergy #RAD2023
Revolutionizing AD retweeted
“I think there's a lot of power in a conference like RAD when it comes to focusing in-depth on one specific subject area where there's so much happening." - @RajMDPhD
Chovatiya is presenting 3 sessions on atopic dermatitis advancements during #RAD2023.
dermatologytimes.com/view/pr…
Revolutionizing AD retweeted
How can @AADmember #dermatologists take their #AtopicDermatitis game to the next level? Master the #basics. My biggest #clinicalpearls for #eczema:
1. Understand the #language
2. Know the #diagnostic #criteria
3. #Rethink the word #classic
4. Start #broad and keep an #openmind
Raj Chovatiya MD, PhD, FAAD, (@RajMDPhD) assistant professor and director for the center for eczema and itch at @NUFeinbergDerm, provides dermatologists and dermatology residents top clinical pearls for treating #atopicdermatitis - https://teapaw.org/t.co/snNNnRHEww
Revolutionizing AD retweeted
In this episode of JAK Inhibitors in the Management of AD, a #FrontLineForum series, Raj Chovatiya, MD, PhD, and Neal Bhatia, MD, share their thoughts on the clinical implications of the rapid expansion of the #atopicdermatitis treatment armamentarium.
ow.ly/TVg950MBgLx
Revolutionizing AD retweeted
Itch isn't the only sensation facing adults with #atopicdermatitis. Pain is a distinct burden, separate from #itch, that affects >50% of adults with AD.
Learn more: nationaleczema.org/itch-vs-p…
#eczema #pain #painrelief #eczemaitch #skincare #skinpain #GetEczemaWise
Revolutionizing AD retweeted
Check out this study of the validity of ICD10 codes for identifying #atopicdermatitis in health services research. You can learn more about these results at the @RevAtopicDerm conference on December 11th.
rdcu.be/cZv7g
#eczema #dermtwitter #allergy #dermatology


















